Literature DB >> 4270254

The treatment of precocious puberty with cyproterone acetate.

K Rager, R Huenges, D Gupta, J R Bierich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4270254     DOI: 10.1530/acta.0.0740399

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


× No keyword cloud information.
  8 in total

1.  The effect of cyproterone acetate on the growth of children with central precocious puberty.

Authors:  R Stanhope; K F Huen; F Buzi; M A Preece; D B Grant
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

2.  Clinical and endocrinologic study of precocious puberty in girls.

Authors:  A Ortner; J Glatzl; E Karpellus
Journal:  Arch Gynecol       Date:  1987

3.  Cyproterone acetate in treatment of precocious puberty.

Authors:  R Kauli; A Pertzelan; R Prager-Lewin; M Grünebaum; Z Laron
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

4.  The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate.

Authors:  R Kauli; R Prager-Lewin; R Keret; Z Laron
Journal:  Eur J Pediatr       Date:  1977-07-01       Impact factor: 3.183

5.  3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors.

Authors:  H J Grill; B Manz; W Elger; K Pollow
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

6.  The child with precocious puberty.

Authors:  S R Marks; M J Elders
Journal:  J Natl Med Assoc       Date:  1979-02       Impact factor: 1.798

7.  Effect of cyproterone acetate on adrenocortical function in children with precocious puberty.

Authors:  D C Savage; P G Swift
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

8.  Cyproterone acetate treatment in precocious puberty.

Authors:  R Lorini; A Colombo; A G Ugazio; A Salvatoni; M Cisternino; D Larizza; E Polito; V Monafo; M Bozzola; F Severi
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.